Ironwood Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.49M | Buy |
21,552
+1,691
| +9% | +$117K | 0.72% | 41 |
|
2025
Q1 | $1.38M | Sell |
19,861
-51
| -0.3% | -$3.54K | 0.75% | 43 |
|
2024
Q4 | $1.71M | Buy |
19,912
+176
| +0.9% | +$15.1K | 0.85% | 33 |
|
2024
Q3 | $2.35M | Buy |
19,736
+31
| +0.2% | +$3.69K | 1.14% | 21 |
|
2024
Q2 | $2.81M | Sell |
19,705
-125
| -0.6% | -$17.8K | 1.5% | 12 |
|
2024
Q1 | $2.55M | Buy |
19,830
+529
| +3% | +$67.9K | 1.24% | 22 |
|
2023
Q4 | $2M | Buy |
19,301
+461
| +2% | +$47.7K | 1.05% | 28 |
|
2023
Q3 | $1.71M | Sell |
18,840
-948
| -5% | -$86.2K | 1.05% | 27 |
|
2023
Q2 | $1.6M | Sell |
19,788
-1,154
| -6% | -$93.4K | 0.92% | 32 |
|
2023
Q1 | $1.67M | Sell |
20,942
-322
| -2% | -$25.6K | 1.04% | 25 |
|
2022
Q4 | $1.44M | Buy |
21,264
+364
| +2% | +$24.6K | 0.95% | 31 |
|
2022
Q3 | $1.04M | Sell |
20,900
-292
| -1% | -$14.5K | 0.73% | 47 |
|
2022
Q2 | $1.18M | Buy |
21,192
+170
| +0.8% | +$9.47K | 0.79% | 42 |
|
2022
Q1 | $1.17M | Sell |
21,022
-1,630
| -7% | -$90.5K | 0.63% | 51 |
|
2021
Q4 | $1.27M | Buy |
22,652
+162
| +0.7% | +$9.08K | 0.63% | 50 |
|
2021
Q3 | $1.08M | Buy |
22,490
+20
| +0.1% | +$960 | 0.56% | 59 |
|
2021
Q2 | $941K | Buy |
22,470
+760
| +4% | +$31.8K | 0.47% | 74 |
|
2021
Q1 | $732K | Buy |
21,710
+832
| +4% | +$28.1K | 0.39% | 93 |
|
2020
Q4 | $729K | Buy |
20,878
+314
| +2% | +$11K | 0.43% | 82 |
|
2020
Q3 | $714K | Buy |
20,564
+436
| +2% | +$15.1K | 0.51% | 79 |
|
2020
Q2 | $659K | Buy |
+20,128
| New | +$659K | 0.51% | 81 |
|